Altimmune
Altimmune focused on the development of products to stimulate robust and durable immune responses for the prevention.
HQ location
Gaithersburg, United States
Website
Launch date
Employees
Market cap
$284m
Enterprise value
$136m
Share price
$3.87 ALT
Recent deals
loading funding rounds…
HealthCap(exited)
Redmont Capital(exited)
Truffle Capital(exited)
ASPR(exited)
Novartis Venture Fund(exited)
University College London(exited)
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (4 %) | (44 %) | 41 % | (46 %) | (102 %) | (726 %) | (95 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (433 %) | (331 %) | (662 %) | (1943 %) | 124856 % | (17727 %) | (474060 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (379 %) | (354 %) | (599 %) | (2201 %) | 124578 % | (20762 %) | (475295 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 179 % | 306 % | 608 % | 1690 % | (103732 %) | 15446 % | 411130 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Altimmune
Edit
ACQUISITION by Altimmune Jan 2017
ACQUISITION by Altimmune Feb 2015